LMDX Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 mai 2024 @ 22:00):

Stats
Dagens volum	120.55M
Gjennomsnittsvolum	0
Markedsverdi	0.00
EPS	$-0.160 ( Q2 \| 2023-06-30 )
Neste inntjeningsdato	( $0 ) 2024-08-22
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0100 (Sector) 42.63 (Industry) 0
ATR14	$0.0140 (93.33%)

ACRS 4.52%

AKU -17.87%

APDN 15.01%

BDSX -1.96%

BIOC 0.00%

BNGO -2.21%

BNR -2.87%

CDNA -1.13%

CEMI 0.22%

CHEK 0.50%

CNTG 0.28%

CSTL -1.42%

DMTK -11.32%

DRIO -5.88%

EXAS 0.36%

FLDM -7.02%

FLGT 0.46%

GENE -0.68%

GH -2.56%

GTH 0.12%

HTGM 0.00%

ICLR 0.75%

IDXX -2.43%

ILMN 0.64%

ISPC -2.36%

LAB -3.38%

LMDX 0.00%

MDXH -2.50%

ME -0.59%

MEDP -0.51%

MYGN -3.60%

MYNZ -15.01%

NDRA -7.43%

NEO 1.73%

NEOG -5.57%

NOTV -3.01%

NTRA -0.74%

OCDX 0.92%

OLK 0.08%

OPGN 0.96%

OPK -2.00%

PMD -2.89%

PRPO 7.19%

PSNL -0.85%

RDNT -1.21%

SERA 3.13%

SHC -2.27%

SQL 0.00%

STIM -4.40%

STRR -3.92%

STRRP -5.05%

SYNH 0.02%

TRIB -4.26%

TTOO 1.12%

TWST 1.70%

VIVO 0.00%

XGN 0.55%

Volum Korrelasjon

Lang: 0.04 (neutral)

Kort: -0.37 (neutral)

Signal:(34.365) Neutral

LumiraDx Limited Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

LumiraDx Limited Korrelasjon - Valuta/Råvare

0.66
( moderate )

0.47
( neutral )

0.00
( neutral )

0.14
( neutral )

-0.79
( moderate negative )

-0.30
( neutral )

LumiraDx Limited Økonomi

Annual	2022
Omsetning:	$254.48M
Bruttogevinst:	$-35.30M (-13.87 %)
EPS:	$-1.590

FY	2022
Omsetning:	$254.48M
Bruttogevinst:	$-35.30M (-13.87 %)
EPS:	$-1.590

Financial Reports:

No articles found.

LumiraDx Limited Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

LumiraDx Limited

LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The company has approximately 30 tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions from the lab to point of need. Its diagnostic testing solutions are deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness, as well as disease. The company was founded in 2014 and is headquartered in London, the United Kingdom.